Literature DB >> 17892485

Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane.

Daxin Peng1, Wei-Gang Hu, Biswa P Choudhury, Artur Muszyński, Russell W Carlson, Xin-Xing Gu.   

Abstract

Lipooligosaccharide (LOS), a major component of the outer membrane of Moraxella catarrhalis, consists of two major moieties: a lipid A and a core oligosaccharide (OS). The core OS can be dissected into a linker and three OS chains. To gain an insight into the biological activities of the LOS molecules of M. catarrhalis, we used a random transposon mutagenesis approach with an LOS specific monoclonal antibody to construct a serotype A O35Elgt3 LOS mutant. MALDI-TOF-MS of de-O-acylated LOS from the mutant and glycosyl composition, linkage, and NMR analysis of its OS indicated that the LOS contained a truncated core OS and consisted of a Glc-Kdo(2) (linker)-lipid A structure. Phenotypic analysis revealed that the mutant was similar to the wild-type strain in its growth rate, toxicity and susceptibility to hydrophobic reagents. However, the mutant was sensitive to bactericidal activity of normal human serum and had a reduced adherence to human epithelial cells. These data, combined with our previous data obtained from mutants which contained only lipid A or lacked LOS, suggest that the complete OS chain moiety of the LOS is important for serum resistance and adherence to epithelial cells, whereas the linker moiety is critical for maintenance of the outer membrane integrity and stability to preserve normal cell growth. Both the lipid A and linker moieties contribute to the LOS toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892485     DOI: 10.1111/j.1742-4658.2007.06060.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

Review 1.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

2.  Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.

Authors:  Dabin Ren; Shengqing Yu; Song Gao; Daxin Peng; Ronald S Petralia; Artur Muszynski; Russell W Carlson; John B Robbins; Chao-Ming Tsai; David J Lim; Xin-Xing Gu
Journal:  Vaccine       Date:  2011-04-16       Impact factor: 3.641

3.  Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Nicole R Luke-Marshall; Katie J Edwards; Shauna Sauberan; Frank St Michael; Evgeny V Vinogradov; Andrew D Cox; Anthony A Campagnari
Journal:  Glycobiology       Date:  2013-05-29       Impact factor: 4.313

4.  Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Authors:  Shengqing Yu; Hang Xie; Anup Datta; Natasha Naidu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

Review 5.  Molecular aspects of Moraxella catarrhalis pathogenesis.

Authors:  Stefan P W de Vries; Hester J Bootsma; John P Hays; Peter W M Hermans
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae.

Authors:  Sarah E Clark; Julian Snow; Jianjun Li; Tracey A Zola; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

7.  High-throughput LPS profiling as a tool for revealing of bacteriophage infection strategies.

Authors:  Eugene E Kulikov; Alla K Golomidova; Nikolai S Prokhorov; Pavel A Ivanov; Andrey V Letarov
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

8.  Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.

Authors:  Rachel Balder; Teresa L Shaffer; Eric R Lafontaine
Journal:  BMC Microbiol       Date:  2013-06-19       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.